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Abstract
Cellular prion protein (PRNP) is a glycoprotein involved in the pathogenesis of transmissible spongiform encephalopathies
(TSEs). Although the physiological function of PRNP is largely unknown, its key role in prion infection has been extensively
documented. This study examines the functionality of PRNP during the course of embryoid body (EB) differentiation in
mouse Prnp-null (KO) and WT embryonic stem cell (ESC) lines. The first feature observed was a new population of EBs that
only appeared in the KO line after 5 days of differentiation. These EBs were characterized by their expression of several
primordial germ cell (PGC) markers until Day 13. In a comparative mRNA expression analysis of genes playing an important
developmental role during ESC differentiation to EBs, Prnp was found to participate in the transcription of a key
pluripotency marker such as Nanog. A clear switching off of this gene on Day 5 was observed in the KO line as opposed to
the WT line, in which maximum Prnp and Nanog mRNA levels appeared at this time. Using a specific antibody against PRNP
to block PRNP pathways, reduced Nanog expression was confirmed in the WT line. In addition, antibody-mediated inhibition
of ITGB5 (integrin avb5) in the KO line rescued the low expression of Nanog on Day 5, suggesting the regulation of Nanog
transcription by Prnp via this Itgb5. mRNA expression analysis of the PRNP-related proteins PRND (Doppel) and SPRN
(Shadoo), whose PRNP function is known to be redundant, revealed their incapacity to compensate for the absence of PRNP
during early ESC differentiation. Our findings provide strong evidence for a relationship between Prnp and several key
pluripotency genes and attribute Prnp a crucial role in regulating self-renewal/differentiation status of ESC, confirming the
participation of PRNP during early embryogenesis.
Citation: Miranda A, Pericuesta E, Ramı ´rez MA ´, Gutierrez-Adan A (2011) Prion Protein Expression Regulates Embryonic Stem Cell Pluripotency and
Differentiation. PLoS ONE 6(4): e18422. doi:10.1371/journal.pone.0018422
Editor: Domingos Henrique, Instituto de Medicina Molecular, Portugal
Received November 23, 2010; Accepted March 6, 2011; Published April 4, 2011
Copyright:  2011 Miranda et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by Grant AGL2009-11358 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: miranda.alberto@inia.es
. These authors contributed equally to this work.
Introduction
Cellular prion protein (PRNP) is a ubiquitous membrane
glycoprotein whose abnormal self-replicating, misfolded form is
widely believed to cause several central nervous system disorders,
collectively known as Transmissible Spongiform Encephalopathies
(TSE) [1]. PRNP is expressed in a broad range of vertebrate tissues
such as spleen, lymph nodes, lung, heart, kidney, muscle and
mammary glands [2,3]. It is also found in the gonads
(spermatogenic cells and ovaries) [4] but most abundantly occurs
in the central nervous system. In embryogenesis, mouse Prnp
mRNA is first highly expressed, mostly in the differentiating
neuroepithelium, between E8.5 and E9, during the transition from
anaerobic to oxidative metabolism [5] and thereafter expands to
non-neuronal tissues at E13.5 [6]. Coupled to the fact that PRNP
is highly conserved across species, these data point to an important
role for this protein. However, actual evidences exist that make
PRNP an absolute mystery. These evidences are that Prnp-
knockout mice [5,7,8], cattle [9] and goats [10] show no drastically
modified developmental phenotype and only display subtle
changes such as synaptic transmission abnormalities [11,12],
disturbed morphology [13], some alterations in circadian rhythm
[14] and cognitive deficiency [15,16,17], suggesting mechanisms
able to withstand the absence of the protein. Similar observations
were made when this gene was inhibited in adult neurons [18]. To
explain these data, it has been hypothesized that another host-
encoded protein is able to compensate for the lack of PRNP [19].
The main candidates for this compensating role are the PRNP-
related proteins Doppel (PRND) and Shadoo (SPRN). The
postembryonic expression of Doppel is restricted to the male
testis, though Prnd mRNA has been detected during embryogen-
esis. Curiously, the absence of Doppel was observed not to provoke
alterations in embryonic and postnatal development, but its
deficiency causes male infertility in mice [20]. In contrast, Shadoo
shows overlapping mRNA expression with Prnp in the brain and
has revealed neuroprotective properties at this site. Shadoo has
also been attributed a role in embryogenesis such that its
downregulation in a Prnp-null embryo invariably gives rise to a
lethal phenotype between E8 and E11 [19]. Hence, both these
proteins play a crucial role in mammalian embryogenesis and
could explain the lack of a severe phenotype in PRNP-knockout
mammals as a step towards deciphering the biological role of this
protein.
The expression of Prnp in embryonic stem cells (ESC) and
immortalized cells has also been addressed. Thus, the expression
of Prnp in mouse ESC is 5 times lower than its expression in the
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18422brain, yet is 1.5 times higher than its expression in somatic cells
[21]. Moreover, during the immortalization of fibroblast MJ90
cells by Tert transfection, Prnp expression is almost three times
greater [22]. In mouse ESC, Prnp is again elevated 1.4 and 6.2
times during the first two weeks of differentiation [23] while during
their guided cardiogenic differentiation, the expression of the gene
is more than 20-fold higher [24]. Curiously, direct reprogramming
of somatic cells (MEFs/B-cells) to a pluripotent state (induced
pluripotent stem cells, iPS) increases the expression of Prnp up to
27-fold [25]. Recently, several studies have associated PRNP with
pluripotency. For example, PRNP has been demonstrated to be a
marker of haematopoietic stem cells, supporting their self-renewal
[26]. Other data indicate that PRNP may be implicated in the
biology of glioblastoma, breast cancer, prostate and gastric cancer
[27,28] or, in other words, PRNP is involved in long term
proliferation as are stem cells. In addition, it has been reported
that the absence of Prnp significantly slows the regeneration process
of acutely damaged hind-limb tibialis anterior muscles of mice
compared to wild-type muscles, affecting the myogenic precursor
cells [29]. Collectively, these findings reveal a physiological
function of PRNP in immortalized pluripotent ESC.
Despite advances made to date, the real function of PRNP is still
unclear with ascribed roles in neuroprotection, the response to
oxidative stress, cell proliferation and differentiation, synaptic
function and signal transduction [30]. The study of the
physiological functions of PRNP seems to be key to understanding
both prion diseases and its possible implications in development
and cancer biology. Given the widely described similarity of
embryoid bodies (EBs) and early postimplantation embryos, we
selected EBs as an ideal model [31]. Herein, by comparing stem
cell differentiation to EBs in Prnp-KO and WT mouse cell lines, we
identify the first non-redundant function of PRNP in ESC
differentiation during early embryogenesis along with a relation-
ship between the expression of Prnp and that of several key
pluripotency markers.
Materials and Methods
Embryo Collection
Mice were kept on a 14-h light/10-h dark cycle. 10-week-old
129/OLA Prnp knock-out female mice were superovulated by
intraperitoneal injections of 10 IU of pregnant mare serum
gonadotropin (PMSG) (Folligon; Intervet, Boxmeer, Holland)
followed 48 hours later by 10 IU of hCG (Chorulon; Intervet). On
the day of hCG injection designated Day 0, the female mice were
paired with males of the same strain to allow mating. After
disinfecting with 70% alcohol and opening the abdominal wall, the
oviducts were excised by clamping, dissecting the peritoneum and
fat between the ovary and tube, and cutting the whole oviduct
from the proximal end. After washing and flushing the oviduct
from the proximal end by incising the whole oviduct with a 30-
gauge needle, two-cell embryos were selected by 100x microscopy.
All the animals were kept in an animal house and handled using
procedures and protocols approved by the Animal Care and
Ethical Committee (Informe CEEA 2009/009) of the Instituto
Nacional de Investigacio ´n y Tecnologı ´a Agraria y Alimentaria (INIA,
Madrid), guidelines of the European Union (Directive 86/609/
EEC) and current Spanish regulations (BOE 252/34367-91,
2005).
Production of ESC and EBs
For ESC production [32], two-cell embryos were collected 1.5
days after hCG injection and placed in a droplet of tempered
KSOM-LIF medium under oil in a 5% CO2 atmosphere at 37uC.
After 48 h in KSOM-LIF, the in vitro cultured blastocysts were
plated individually in 96-well plates coated with 0.1% gelatine and
containing mitomycin-C (Sigma-Aldrich corporation St. Louis,
MO, USA) treated mouse embryonic fibroblasts (MEF). They
were cultured in ESC medium composed of Dulbecco’s modified
Eagle medium (DMEM plus 4500 mg/l glucose, glutaMAX, and
pyruvate; Invitrogen, Carlsbad, CA, USA) supplemented with
20% FBS (PAA Laboratories Co ¨lbe Germany), 2 mM glutamine,
1 mM MEM nonessential amino acids solution, 1 mM b-
mercaptoethanol, 1000 U/ml LIF (leukemia inhibitory factor),
and an antibiotic mixture containing 100 U/ml penicillin and
100 mg/ml streptomycin. The blastocysts were allowed to attach to
the MEF, until expansion without any further experimental
interference for four days. After that time, cell clumps originating
from the blastocysts were trypsinized and pipetted directly into a
well of a 96-well plate containing MEFs and ESC medium.
Approximately 4 days after trypsinization, compact cell colonies
resembling ESC colony morphology could be detected and these
cells were trypsinized in a 24-well plate containing MEFs and ESC
medium. In this process, undifferentiated ESCs were separated
from differentiated ones and from old MEF, and also expanded in
number. Clones that were not confluent were replated on the same
plate. When trypsinizing cells from a 35-mm dish for the first time
for a particular clone, half the cells were frozen at 280uC in foetal
calf serum with 10% DMSO media. This was considered the first
passage. For cell line expansion, cells were trypsinized at 80% of
confluency.
For embryoid body (EB) differentiation [33], ESC colonies were
digested with 0.05% trypsin-EDTA. The dissociated cells were
collected in EB medium (DMEM plus (4500 mg/l glucose,
glutaMAX, and pyruvate) supplemented with 20% FBS, 2 mM
glutamine, 1 mM MEM nonessential amino acids solution, 1 mM
b-mercaptoethanol, and an antibiotic mixture containing 100 U/
ml penicillin and 100 mg/ml streptomycin and plated on a
gelatine-coated dish for 45 min to allow the MEF cells to adhere.
Non-adherent cells were collected and plated onto non adherent
plastic Petri dishes in the same EB medium. The medium was
replaced every 2 days.
RNA Extraction, Reverse Transcription, and mRNA
Transcript Quantification
RNA was prepared from ESC or EBs of each experimental
group (WT or Prnp KO) using the ULTRASPEC total RNA Isolation
Reagent Kit (BIOTECX laboratories, INC) according to the
manufacturer’s instructions. Immediately after extraction, the
RT reaction was carried out following the manufacturer’s
instructions (Promega, Madrid, Spain) to produce cDNA. Tubes
were heated to 70uC for 5 min to denature the secondary RNA
structure, allowing Random Primer and Oligo dT attachment,
and then the RT mix was completed with the addition of 5 units of
Superscript RT enzyme. The tubes were then incubated at room
temperature for 10 min and next at 42uC for 60 min to allow the
reverse transcription of RNA, followed by 70uC for 10 min to
denature the RT enzyme. To detect each transcript, we used 2 ml
of the cDNA sample in the RT-PCR.
mRNA transcripts were quantified by real-time qRT-PCR [34].
At least three replicate PCR experiments were conducted for all
the genes of interest. Experiments were designed to contrast
relative levels of each transcript and histone H2az in each sample.
PCR was performed by adding a 2- ml aliquot of each sample to
the PCR mix (Quantimix Easy Sig Kit, Biotools) containing the
specific primers. Primer sequences, annealing temperatures, and
the approximate sizes of the amplified fragments of all transcripts
are provided in Table 1. The comparative cycle threshold (CT)
Prion Protein and ESC Differentiation
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Prism 7700 Sequence Detection System, Applied Biosystems). Quanti-
fication was normalized to the endogenous control H2az.
Fluorescence was acquired in each cycle to determine the
threshold cycle or the cycle during the log-linear phase of the
reaction at which fluorescence increased above background for
each sample. Within this region of the amplification curve, a
difference of one cycle is equivalent to doubling the amplified PCR
product. According to the comparative CT method, the CT value
was determined by subtracting the H2az CT value for each sample
from the CT value of each gene in the sample. CT was calculated
using the highest sample CT value (i.e., the sample with the lowest
target expression) as an arbitrary constant to be subtracted from all
other CT sample values. Fold changes in the relative gene
expression of the target were determined using the formula 2
–CT.
Statistical Analysis
Data were analyzed using the SigmaStat (Jandel Scientific, San
Rafael, CA) package by one-way repeated-measures ANOVA with
arcsine data transformation.
Semiquantitative PCR
cDNA was obtained as described above and PCR was
performed with a PCR mix (Go taq Flexi DNA polymerase Kit,
Promega) following the manufacturer’s instructions. The PCR
products were analyzed on a 2% agarose gel by ethidium bromide
staining. The gel was visualized under ultraviolet light to identify
the specific band for each gene analyzed.
Antibody Inhibition Experiments
EBs of both ESC lines were re-suspended on Day 5 in EB
medium alone or supplemented with SHA31 anti-mouse PRNP
antibody (CISA, INIA), with anti-rabbit ITGB5 antibody
(ABCAM) or control antibody (mouse IgG) at final concentrations
in the medium of 0.2 mg/ml. The EBs were collected 6 or
24 hours later and frozen for mRNA extraction.
Terminal Deoxynucleotidyl Transferase-Mediated dUTP
Nick End-Labelling (TUNEL) Assay
For the TUNEL method of detecting apoptosis, EBs cultured
for 5 days were fixed in 4% paraformaldehyde in PBS, pH=7.4,
for 1 h, and then washed in PBS/1%BSA three times. The fixed
EBs were permeabilized with 0.1% Triton X-100 in PBS for
15 min at 37uC and then washed again in PBS/1%BSA three
times. TUNEL assays were performed using the In Situ Cell Death
Detection Kit, TMR Red (Roche) according to the manufacturer’s
protocol. As control, it was checked that a lack of TdT in the
TUNEL mix completely abolished labelling.
Results
Two distinct types of Prnp-KO EBs exist
Two lines of Prnp-KO ESC were produced in a 129Ola
background (that of the WT control line R1). Since both these
lines develop in the same way, the results for each line were
collectively considered. Confluent WT and KO ESC lines were
trypsinized and grown in a LIF-free medium without the feeder
layer to form EBs. From Days 1 to 3, large numbers of unclustered
cells could be seen among the KO EBs. This could be the reason
of a significantly reduced EB numbers on Day 5 (Fig. 1A). TUNEL
apoptosis analysis on Day 5 of ESC differentiation revealed a low
number of isolated cells positive for immunostaining in the WT
line (Fig. 1B) (2–5% of the WT EB surface). Extensive apoptotic
red zones were detected in the KO EBs on Day 5 of differentiation
(10–15% of the KO EB surface), which could explain the high
number of floating cells observed in the early EB culture
supernatants. Interestingly, two types of EBs were observed on
Day 5 in the KO group. About 40% of the EBs were white
showing no apoptosis signal, and 60% were morphologically
Table 1. Primers used for RT-PCR.
Gene Primer sequence 59-.39 Size GenBank
Prnp GATTATGGGTACCCCCTCCTTGG 289 NM_011170.2
ATGGCGAACCTTGGCTACTGGC
Nanog AGGGTCTGCTACTGAGATGCTCTG 363 M6047
CAACCACTGGTTTTTCTGCCACCG
Pouf51
(Oct3/4)
GGAGAGGTGAAACCGTCCCTAGG 391 M17031
AGAGGAGGTTCCCTCTGAGTTGC
Genesis
(Foxd3)
TCTTACATCGCGCTCATCAC 171 M4758
TCTTGACGAAGCAGTCGTTG
Stat3 CAGAAAGTGTCCTACAAGGGCG 340 U06922
CGTTGTTAGACTCCTCCATGTTC
Mapk1 CCTTCAGAGCACTCCAGAAAGT 74 NM_011949.3
ACAACACCAAAAAGGCATCC
Gp130 ATTTGTGTGCTGAAGGAGGC 186 M83336
AAAGGACAGGATGTTGCAGG
Itgb3 GTCACATTGGCACCGACAACC 556 NM_016780.2
CCACACTCAAAAGTCCCGTTC
Itgb5 GGCTGCTGTCTGCAAGGAG 511 M96614
TCAAAGGATGCCGTGTCC
Itga6 GTGAGGTGTGTGAACATCAG 540 NM_008397.3
CATGGTATCGGGGAATGCT
Shadoo TTGGCCTGTACAAAGTTGAG 186 NM_183147.2
CTGCAATGAGGGAAAAGCCT
Prnd
(Doppel)
GCTCCAAGCTTCAGAGGCCACAGTAGCA 580 M1346999
TTACTTCACAATGAACCAAACGAAAC
Sod1 GGGATTGCGCAGTAAACATTC 67 NM_011434.1
AATGGTTTGAGGGTAGCAGATGA
Slc2a1 CCAGCTGGGAATCGTCGTT 76 M23384
CAAGTCTGCATTGCCCATGAT
Irs2 CTCTGACTATATGAACCTG 339 NM_001081212.1
ACCTTCTGGCTTTGGAGGTG
Gapdh ACCCAGAAGACTGTGGATGG 247 BC102589
ATGCCTGCTTCACCACCTTC
T
(Brachyury)
GCTGTGACTGCCTACCAGCAGAATG 220 M913
GAGAGAGAGCGAGCCTCCAAAC
Hnf3-b GGACGTAAAGGAAGGGACTCCAC 174 M938
AGCCCATTTGAATAATCAGCTCAC
Nestin AGTGTGAAGGCAAAGATAGC 316 M23742
TCTGTCAGGATTGGGATGGG
H2AZ AGGACGACTAGCCATGGACGTGTG 212 NM_016750
CCACCACCAGCAATTGTAGCCTTG
doi:10.1371/journal.pone.0018422.t001
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of differentiation (more than 80 days) while in the WT line, only a
small number of EBs looked white after 5 days of differentiation
(1–2%) and these disappeared over the following 2 days (Fig 1C).
In addition, after 30 days of differentiation, mature EBs in both
KO populations were plated on a feeder layer in complete stem
cell medium (including LIF and bFGF), and after 3 passages, we
could only recover cells positive for alkaline phosphatase of the
white KO population. mRNA was extracted from the different
types of EB and it was noted that Gp130 and Stat3 (proteins
involved in maintaining pluripotency) were upregulated only in the
white KO population (data not shown).
Prnp–KO ESC and EBs express different pluripotent
markers to the WT line during differentiation
The mRNA expression of pluripotency markers was examined
in both the WT and Prnp–KO lines. We selected the genes Oct3/4
(Pou5f1), Nanog, and FoxD3 (Genesis) because the feedback regulating
cycle of these genes is among the most important for maintaining
stem cell pluripotency [35]. Stem cells from the WT line showed
significantly higher Nanog and Oct3/4 and lower FoxD3 transcript
levels than KO ESC (Fig. 2A and 2B), indicating a different
background of pluripotency in the KO and WT lines.
In order to better understand the role of PRNP in differentiation,
Prnp mRNA was quantified from the ESC stage (Day 0) to Day 13
EBs. Stem cell lines were cultured in ESC medium without LIF and
samples were taken on Days 0, 1, 2, 3, 5, 7 and 13. Next, mRNA
wasextracted andtranscriptswerequantifiedbyqRT-PCR.During
WT EBs differentiation, Prnp showed increasing levels of expression
starting on Day 2 until Day 7, showing peak expression on Day 5
(Fig. 2C). In the WT line, no significant differences could be
detected in mRNA levels of FoxD3 until Day 13 when an expression
increase was observed (Fig. 2A). However, Prnp expression was
negatively correlated with that of the pluripotency marker Oct-4.
Thus, higher Oct-4 expression levels were detected on Days 0 and 1
followed by reduced expression until Day 13, following an opposite
expression pattern to Prnp and confirming that ES cells had indeed
differentiated. Nanog was also downregulated on Day 13, accord-
ingly with the differentiation status. Interestingly, Nanog expression
showed a similar pattern to Prnp, with increasing expression levels
observed from Day 2 to Day 7 peaking on Day 5 (Fig. 2A). In
contrast, in the KO line, Oct-4 and FoxD3 expression levels showed
some variation during early differentiation but high mRNA levels
persisted on Days 7 and 13 (Fig. 2B). Further, Nanog expression
levels were highest on Day 13, indicating the pluripotent state of
these cells even after 13 days of differentiation (Fig. 2B).
To understand this initial developmental status of the different
pluripotency markers in the KO ESC, we examined the expression
of bone morphogenetic protein (BMP) genes, which are related to
the germ cell program. These genes were chosen because KO EBs
show characteristics comparable to those of germ cells, as the only
cells in the organism that repress their somatic differentiation
program in favour of a germline-specific network of RNA
regulation. Indeed, BMPs regulate the differentiation of PGCs
and are also able to potentiate pluripotency in the presence of LIF.
Our semiquantitative PCR revealed increased expression levels of
all the PGC markers in the KO stem cells, regardless of the stem
cell line (Fig. 3A). The expression of two later PGC markers, Mvh4
(Ddx4) and Dazl (Fig. 3B), was lacking in the WT line but was
detected in WT cells grown in a GS medium and in the KO lines.
When we assessed the same markers during the time course of EB
differentiation, it was found that early (Bmp4) and intermediate
[Fragillis (Ifitm3)a n dStella (Dppa3)] PGC markers (Fig. 3B) were
upregulated on Day 5 in WT EBs and that these were gradually
replaced with the later expressed Mvh4 and Dazl from Day 7 to 13
(Fig. 3C). The same occurred in normal-appearance KO EBs, but in
the white EB population all these markers persisted at all the time
points. For this reason, we called the white EBs derived from the KO
ES cells PGC-like to differentiate them from the KO EBs of similar
morphological appearance to WTEBs (designated WT-likeKO EBs).
Characterizing the WT and Prnp-KO lines during
differentiation to EBs
The appearance of two EB populations in the KO line could be
the consequence of two different ways of compensation and
expression of Shadoo and Doppel, two genes whose functions are
redundant to those of Prnp in some tissues and developmental
stages. Accordingly, we then examined mRNA levels of these
genes during the time course of EB differentiation. In addition, to
determine if the differences between the three types of EBs were
due to differences in tissue differentiation, we analyzed the mRNA
expression of early markers of ectoderm (Nestin), mesoderm
(Brachury -T-) and endoderm (Hnf3) (Fig. 4). We considered it
might be also interesting to determine the metabolic state of these
EB populations since PRNP is thought to be involved in protection
from oxidative stress [30]. Thus, we examined mRNA levels of
glucose capturing genes (Slc2a and Irs2) and glycolysis genes
(Gapdh) (Fig. 5) giving information about oxidative metabolism,
and mRNA levels of the SOD1 gene (Sod1), which codes for a
protein whose antioxidant activity is regulated by PRNP [36,37].
WT ESC expressed all the transcripts except Nestin in higher
amounts than the KO ESC (Fig. 4, Day 0). Interestingly, during
Figure 1. Apoptotic and macroscopic effects produced by the
delection of Prnp. A) Comparing the numbers of EBs in the WT and
KO lines (* P,0.05. Error bars, s.e.m.; ‘‘Y’’ axis represents ‘‘number of EBs
per plate’’) B) TUNEL analysis of wild type (WT) and Prnp-null (KO)
embryoid bodies (EBs). C) Morphology of EBs on Day 7 and Day 80 of
differentiation. The KO ESC line produced 2 types of EBs: one similar to
WT (*) and the other called PGC-like KO EBs (arrowheads).
doi:10.1371/journal.pone.0018422.g001
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raised and maintained from Day 5 in the PGC-like KO EBs (Fig. 4)
compared to WT and WT-like KO EBs, which showed similar
expression among each other. However, in the WT-like KO EBs
the absence of PRNP resulted in non-expression of Nestin on Day
13 (Fig 4) suggesting a role for PRNP in neural cell differentiation
during early embryogenesis. This phenomenon was not observed
in the PGC-like KO EBs since these cells maintained similar
transcription levels during the differentiation time examined.
On the other hand, the mRNAs of Irs2, Slc2a, Gapdh and Sod1
were augmented in the PGC-like KO EBs on Days 5 and 7 (Fig. 5).
Gapdh mRNA was also elevated on Day 5 in WT-like KO EBs but
reached baseline levels on Day 7, suggesting a transition feature.
This metabolic situation was maintained until Day 13 in both
kinds of KO EB (data not shown) and indicates enhanced
glycolytic and oxidative metabolism in the PGC-like KO EBs.
Stat3 mRNA is upregulated in the later stages of
differentiation
Our experimental protocol includes the use of LIF-starved ES
medium, so the receptor (Gp130) and main effector genes (Erk1/2
and Stat3) of the LIF pathway were analysed. ERK 1/2 is known
to be involved in the loss of pluripotency and is also a downstream
component of the PRNP biochemical matrix, while STAT3
contributes to the maintenance of self-renewal. WT EBs showed
lower expression of Erk1/2 mRNA than PGC-like KO EBs,
disappearing on Day 13 (Fig. 6). The same lower levels were
observed for Stat3 in the WT EBs, but disappearing on day 7.
However, in the PGC-like KO EBs, increased transcription of this
gene was observed on Day 13, indicating and supporting the
previously described pluripotent state of these EBs. In contrast,
Gp130 expression failed to vary or only showed subtle variations
during the time course of differentiation, indicating that the
upregulation of Stat3 transcription is not related to activation of the
LIF pathway.
Prnp regulates Nanog mRNA expression
On Day 5 of EB differentiation, the highest levels of Prnp and
Nanog were detected in the WT EBs. Similar waves in their
mRNA expression pattern were also observed suggesting Prnp-
dependent Nanog transcription (Fig. 2A and Fig. 2C). To
confirm this relationship, we conducted Prnp inhibition
Figure 2. Pluripotency in the WT and Prnp-null cell lines. WT EB mRNA (A) and KO EB mRNA (B) expression patterns of three pluripotency
genes during differentiation. Note the lack in the KO line (B) of an increase in Nanog expression on Day 5. C) WT EB mRNA expression pattern of Prnp
during differentiation (Days 0, 1, 2, 3, 5, 7 and 13). Prnp is expressed at its highest levels on Day 5 (Error bars, s.e.m.).
doi:10.1371/journal.pone.0018422.g002
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specific PRNP antibody to the culture medium inactivates this
protein’s signal transduction pathways [38,39] so we proceeded
to add the monoclonal antibody Sha31 to WT EBs on Day 5.
Interestingly, a significant reduction in Nanog mRNA levels was
detected, even over the shorter time interval (6 h) (Fig. 7), and
this effect persisted for 24 hours without refreshing the
antibody (data not shown). Further, mRNA expression patterns
of important PRNP related markers on Day 5 (e.g. integrins
avb5a n da6 and the metabolic gene Sod1), which were
differentially expressed between the PGC-like KO EBs and WT
EBs, became similar (data not shown). This inhibition of Nanog
expression confirms the involvement of Prnp during EB
differentiation.
Nanog expression on Day 5 is blocked by integrin beta5
in Prnp-KO EBs
Integrins are essential for PGC functionality [40,41] and it has
been reported that the absence of Prnp may be compensated by
these proteins [42,43]. Since integrin signalling is crucial in
promoting mouse ESC self-renewal [44], we speculated that Prnp
expression might also be related to this integrin expression during
ESC differentiation. So we examined by real time PCR the
transcription levels of three genes coding for integrins avb3( Itgb3),
avb5( Itgb5), and a6( Itga6) in stem cells and during early EB
differentiation (Days 5, 7, and 13). We found that Itgb3 was only
detected in PGC-like KO EBs on Day 5. Similar transcription levels
of Itga6 were found in the KO stem cells and in the WT line.
During differentiation, significantly elevated expression was
observed on Day 5 in the Prnp-KO background population; this
transcription gradually fell from Day 7 to 13. In the WT,
expression was increased only on Day 13 (Fig. 8A). Interestingly,
mRNA for Itgb5, described to be a gonadal tissue marker [41],
appeared in higher amounts in the WT ESC than in the KO ESC;
however, expression was higher in the PGC-like KO EBs at all the
differentiation times (Fig. 8A).
Because the expression of Itgb5 on Day 5 differed significantly
between WT and KO, we designed an Itgb5 antibody mediated
inhibition experiment to analyse its effect on the transcription
patterns observed on Day 5 of EB differentiation. Surprisingly,
when ITGB5 was blocked at the membrane level in the PGC-like
KO EBs, Nanog mRNA transcription was significantly augmented,
while in the WT line, this treatment had no significant effect
(Fig. 8B). These results indicate that in the absence of Prnp, the
expression of Nanog on Day 5 of EB differentiation may be partially
mediated by the inhibition of this integrin.
Figure 3. Consequences of Prnp absence in the BMP pathway. A) Detection of PGC markers (Bmp4, Fragillis, Stella, Mvh4 and Dazl) in WT ESC,
WT GS and the two different Prnp KO ESC lines (KO 1 and KO 2) by PCR. Knock out cells show all the PGC markers analyzed in stem cell state. B)
Diagram representing the BMP pathway showing the early, intermediate and later PGC markers (figure adapted from Young et al. 2009). C) Detection
of primordial germ cell markers (Bmp4, Fragillis, Stella, Mvh4 and Dazl) by PCR during differentiation in WT EBs, WT-like KO EBs and PCG-like KO EBs.
doi:10.1371/journal.pone.0018422.g003
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to a role for both genes in the development of the foetal
gonads
We quantified the in vivo transcription of Prnp and Nanog in the
brains, testicles and ovaries of E16.5 WT mouse foetuses, neonates
and adults. These tissues were selected because Prnp-KO ESC and
their derived EBs showed an ectodermal gene expression pattern.
In brain, as expected, Prnp was highly expressed, with no Nanog
expression detected in any case (Fig. 9). In the testicles, a clear
increase in Prnp mRNA levels was seen during the foetal period;
and in the ovaries, this was observed in the foetal and neonatal
period. Nanog expression in these two tissues was upregulated at the
same time points as Prnp except in adult testicles, where Nanog
showed clear upregulation contrary to the behaviour of Prnp.
However, Doppel was upregulated at this point (data not shown)
and could explain the absence of Prnp expression in the adult
testicle. These results indicate that correlative Nanog-Prnp mRNA
expression, possibly due to Nanog Prnp-dependant transcription as
was seen in the ‘‘in vitro’’ experiments, occurs in the gonads but not
in neuronal tissues.
Figure 4. Differentiation transcription behaviour of the WT and Prnp-null cell lines. mRNA expression patterns of PRNP related proteins
(Doppel and Shadoo) and early markers of endoderm (Hnf3), mesoderm (Brachyury -T-) and ectoderm (Nestin) in WT and KO stem cells and in WT, WT-
like KO and PGC-like KO EBs during differentiation (Days 5, 7 and 13). (* indicates statistical differences for the transcription of each gene between WT
and KO ESC at P,0.05) (Error bars, s.e.m).
doi:10.1371/journal.pone.0018422.g004
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The key role of prion protein in infection has been
expansively reported, yet its physiological function remains
elusive. To address this issue, we designed a comparative
analysis during differentiation of WT and Prnp-KO ESC. In
the current study, we employed ESC to assess the potential
role of PRNP in early embryo development, examining how
this locus becomes transcriptionally activated when potential
transient compensatory mechanisms are still not established.
We here present the first evidence that Prnp is involved in
regulating the self-renewal/differentiation status of stem cells.
Its expression was found to affect that of several pluripotent
genes, including Nanog, a protein that drives constitutive stem
cell self-renewal and safeguards pluripotency [45,46] through
its involvement in the Sox2-Oct3/4 transcription factor
network [47,48,49,50,51].
The main pathway through which ESC-derived cells become
differentiated cells involves the formation of embryoid bodies,
thus denoted because of their similarity to the early postimplan-
tation embryo. Embryoid bodies are formed ‘‘in vitro’’ after
several days of growth of ESC in the absence of LIF (leukemia
inhibitory factor). These bodies are the final ESC population that
has the potential to give rise to all the cell types of adult tissues
and have been described as the developmental equivalent of the
egg cylinder-stage mouse embryo, with an outer endodermal
layer and a core of differentiating cells, often comprised of
epithelial-lined cavities [52]. Hence the data obtained in this
Figure 5. Metabolic transcription behaviour of the WT and Prnp-null cell lines. WT, WT-like KO EB and PGC-like KO EB mRNA expression
patterns for Irs2 (Insulin Receptor Substrate 2), Slc2a (Glucose Transporter 1 - Glut1 -), Gapdh (Glyceraldehyde 3-phosphate Dehydrogenase) and Sod1
(Superoxide Dismutase 1) on Days 5 (A) and 7 (B). (Error bars, s.e.m.).
doi:10.1371/journal.pone.0018422.g005
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development.
Our results indicate that despite the widespread expression of
key genes of pluripotency in WT and Prnp-KO ESC lines (e.g.,
Oct4) and their characteristic undifferentiated cell morphology,
functional ESC may represent only a small fraction of the total
number of cells grown under self-renewal conditions. Effectively,
in our KO ESC, a large PGC-like stem cell population was
identified. Further, mRNA levels of early endoderm and
mesoderm markers were significantly lower, while early neuronal
ectoderm marker mRNA levels were fairly similar to those in WT
ESC. Taken together with the fact that PGC markers were also
expressed, an ectodermal stem cell type was defined in the KO ESC,
according to the simple absence of Prnp. Indeed, a heterogeneity in
the stem cell population leading to different transcription behavior
has been previously described based on Nanog mRNA levels [53].
This could explain the appearance of two different kinds of EB
when LIF was removed from the culture medium in the KO line,
based on the detected absence of Nanog transcription in this EB
population. Thus, phenotypically ‘‘undifferentiated’’ cells may
consist of a heterogeneous population of functionally distinct cell
types, and small changes in gene expression could lead to the
predominance of one of these types over the others.
Interestingly, in Prnp-KO ESC, Doppel and/or Shadoo were
clearly downregulated. However, on Day 5, PGC-like KO EBs
overexpressed Doppel and Shadoo, showing the altered expression
of early embryo layer markers and also enhanced glucose and
oxidative metabolism. This last feature has been related to a high
rate of proliferation in cancer or stem cells (Warburg effect)
[54,55] and to increased protection against oxidative stress,
according to the high pluripotency level of these PGC-like KO
EBs and to compensation for the high sensitivity to oxidants of the
KO lines, respectively. Until now, Doppel and Shadoo, ascribed to
the PRNP family, were known to compensate for the absence of
PRNP, having redundant (in the case of Shadoo in brain [19]) or
exclusive (in the case of Doppel in male testicles [20]) functions.
However, we noted that WT-like KO EBs exhibited similar
expression patterns of these genes with subtle differences in
comparison to WT EBs. Thus, we could speculate that an ESC,
lacking Prnp yet showing increased Doppel and Shadoo gene
expression during differentiation, will give rise to a living system
closely resembling PGCs, morphologically different to WT cells,
more metabolically active in terms of differentiation [55] and with
a high degree of pluripotency. Conversely, if Doppel and Shadoo
were not overexpressed, KO EBs would be practically identical to
their WT counterparts. Our results therefore suggest that the
absence of PRNP is not counteracted by the presence of Doppel
and Shadoo, as previously thought. The two different populations
of KO EBs with a completely different expression pattern for these
genes, further supports the idea of an irreplaceable role of PRNP
in this process, most likely in coordinating the expression of
indispensable proteins for the appropriate behaviour of the stem
cells.
Recently, it has been indicated that during certain embryogen-
esis processes some redundancy for PRNP interactions resides
within the integrin pathway [43], and that integrin signalling is
crucial for promoting mouse ESC self-renewal [44]. Here, we
analysed the expression of three integrins during PRNP-null stem
cell differentiation to investigate if these integrins play some sort of
Figure 6. LIF pathway regulation in the WT and Prnp-null cell
lines. WT EB mRNA (A) and PGC-like KO EB mRNA (B) expression
patterns of some LIF pathway genes during differentiation (Days 0
[(Stem Cell], 5, 7 and 13). (*indicates significant differences for a
particular gene between WT and PGC-like KO EBs (P,0.05)) (Error bars,
s.e.m.).
doi:10.1371/journal.pone.0018422.g006
Figure 7. Blocking of PRNP by the monoclonal antibody Sha31.
On Day 5 and after 6 hours of antibody treatment, it is revealed that
Nanog mRNA transcription is PRNP-dependent during differentiation
and independent of feedback from the pluripotency cluster genes Oct3/
4 and FoxD3. (Error bars, s.e.m.).
doi:10.1371/journal.pone.0018422.g007
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(ITGB3) and integrin avb5 (ITGB5) are expressed in mouse foetal
developing gonads (from Days 10.5 to 13.5); ITGB3 is specific to
primordial germ cells [41] and ITGB5 plays important roles in
maintaining stemness in undifferentiated mouse ESC [56]. The
observation of Itgb3 transcription only on Day 5 in the KO EB
population indicated primordial germ cell transcription activity at
this stage. Moreover, the higher expression of Itgb5 on Days 5, 7
and 13 was in agreement with the presence of the primordial germ
cell markers identified in the PGC-like KO EBs. It has been reported
that integrin-a6 (ITGA6) function is required for the early stages
of lens cell differentiation [57]. The higher expression of Itga6 we
identified on Day 5 in KO EBs, and on Day 13 in the WT EBs,
could point to the cell differentiation activity of PGCs in the KO
EBs, and of the three embryonic layers in the WT line.
Our results also indicate a relationship between PRNP and
integrins in ES cells and during differentiation. It has been shown
that PRNP binds some extra cellular matrix (ECM) proteins
[43,58,59], and other important ECM proteins, such as integrins,
could also interact or cooperate with PRNP in this process.
Integrins have been the focus of several studies over the past few
years, not only because of their capacity to bind ECM, but also
because of their ability to activate a number of cell signaling
pathways, including those of differentiation and pluripotency
[44,56]. It is also known that Prnp downregulates Itgb3 mRNA
expression in Mesenchymal Embryonic Cells (MEC) [42],
highlighting the importance of integrins in the PRNP biochemical
matrix. Other authors have determined that PGCs contain
subpopulations showing low or null integrin-a6 (ITGA6) expres-
sion with a greater ability to develop into pluripotent stem cells
[40]. The fact that several authors have also related the
upregulation of certain integrin transcription with a loss of
pluripotency and self-renewal [44], suggest a pivotal link between
PRNP or integrins and these processes. Our results revealed that
Itga6, Itgb3 and Itgb5 were deregulated in the KO line. Specifically,
Itgb3 (data not shown) and Itgb5 mRNAs appeared in high
quantities in the PGC-like KO EBs on Day 5 and, only for the last
gene, this population of EBs was labelled by this integrin for longer
Figure 8. Influence of Prnp in the integrin matrix. A) Detection of PRNP-related integrins (Itga6 and Itgb5) in WT and KO stem cells on Day 0, and
in WT EBs and PGC-like KO EBs on Days 5, 7 and 13. B) Blocking of ITGB5 by a polyclonal antibody shows that Nanog mRNA transcription is ITGB5-
dependent during differentiation (*indicates significant differences between WT and PGC-like KO EBs on a particular day (P,0.05)) (Error bars, s.e.m.).
doi:10.1371/journal.pone.0018422.g008
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are confirmed PGC and gonadal tissue markers, respectively, this
suggests the idea of arrested EBs in that ectoderm cell line, also
consistent with the loss of self-renewal in a situation of high
integrin expression [44].
In addition, the expression of Erk1/2, previously incriminated in
differentiation, was significantly downregulated on Day 13 in the
PGC-like KO EBs, at the same time an increase in Stat3
transcription and downregulation of Itga6 were observed. These
results suggest that PGC-like KO EBs seemed to acquire pluripotent
and PGC self-renewal characteristics on Day 13. Further, in our
antibody-mediated inhibition experiments, when ITGB5 was
blocked on Day 5 at the membrane level in the PGC-like KO
EBs, the important pluripotency mRNA transcript Nanog was
significantly elevated, while this treatment had no effect in the WT
line, though a non-significant upward trend was observed. Similar
results were reported when mouse ESC cultured on laminin or
fibronectin (activators of integrin pathways) in ESF7 medium
showed low immunostaining for alkaline phosphatase, weak
immunostaining in immunocytochemical experiments detecting
NANOG and a low population of NANOG positive cells in flow
cytometric analysis [44]. However, when the mouse ESC was
treated with an anti-b1 integrin antibody (blocking the interaction
ECM-integrins) these findings were reversed [44].
We also observed here that the disruption of PRNP by knocking
out through transgenesis or knocking down through antibody
inhibition led to diminished Nanog mRNA levels (especially on Day
5, when peak Prnp and Nanog were observed in the WT line),
accompanied by high levels of Itgb5 mRNA. These data thus
indicate the possible Prnp regulation of Nanog transcription via Itgb5
during early differentiation to EBs. Moreover, the results of our ‘‘in
vivo’’ experiments suggest that this relationship during early
differentiation between Prnp and Nanog specifically occurs in
gonadal but not in brain tissue. In summary, our data point to the
first known relationship between PRNP and NANOG, one of the
most important proteins needed to maintain pluripotency, with a
major role in the self-renewal of ESC and their differentiation into
gonadal cells.
A loss of PRNP functionality was largely proposed as one of the
main causes of a prion disease physiopathology. There is a lack of
a premortem way of detecting them and bearing in mind that Nanog
levels remain low or disappear during the first stages of
differentiation of Prnp-KO ESC, the use of this gene as a marker
of prion disease and, more importantly, as an early detection
method could be investigated. Otherwise, PRNP is not essential
for ESC survival since other pathways could support its absence,
although a significant percentage of cells die in the first stages of
differentiation to EBs. In contrast, Prnp knockout or downregula-
tion modifies the normal macroscopic and transcriptional
behaviour of the stem cell during differentiation, confirming the
participation of PRNP in early embryogenesis [19]. The
association between Prnp and pluripotency marker expression also
provides evidence of this contribution of Prnp to stem cell
differentiation (e.g. the role of PRNP in neural cell differentiation
[60]). This feature is mediated by Nanog and not compensated by
the PRNP-related proteins Doppel and Shadoo, suggesting for the
first time a non-redundant function of PRNP in maintaining
pluripotency and differentiation during early embryogenesis.
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